Literature DB >> 22915618

Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA).

Jan M Hughes-Austin1, Kevin D Deane, Lezlie A Derber, Jason R Kolfenbach, Gary O Zerbe, Jeremy Sokolove, Lauren J Lahey, Michael H Weisman, Jane H Buckner, Ted R Mikuls, James R O'Dell, Richard M Keating, Peter K Gregersen, William H Robinson, V Michael Holers, Jill M Norris.   

Abstract

OBJECTIVE: We investigated whether rheumatoid arthritis (RA)-related autoantibodies were associated with systemic inflammation in a prospective cohort of first-degree relatives (FDRs) of RA probands, a population without RA but at increased risk for its future development.
METHODS: We studied 44 autoantibody positive FDRs, of whom 29 were rheumatoid factor (RF) positive, 25 were positive for the high risk autoantibody profile (HRP), that is, positive for anti-cyclic citrullinated peptide and/or for at least two RF IgM, IgG or IgA isotypes, and nine FDRs who were positive for both; and 62 FDRs who were never autoantibody positive. Twenty-five cytokines/chemokines were measured using a bead-based assay in serum. As a comprehensive measure of inflammation, we calculated a Cytokine Score by summing all cytokine/chemokine levels, weighted by their regression coefficients for RA-autoantibody association. We compared C-reactive protein, individual cytokines/chemokines and Cytokine Score to the outcomes: positivity for RF and for the HRP using logistic regression.
RESULTS: Adjusting for age, sex, ethnicity and ever smoking, the Cytokine Score and levels of IL-6 and IL-9 were associated with both RF and HRP. IL-2, granulocyte macrophage-colony stimulating factor (GM-CSF), and interferon (IFN)-γ were associated with HRP only. Associations between the Cytokine Score and RF and HRP positivity were replicated in an independent military personnel cohort.
CONCLUSIONS: In first-degree relatives of patients with RA, RA-related autoimmunity is associated with inflammation, as evidenced by associations with multiple cytokines and chemokines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22915618      PMCID: PMC3726193          DOI: 10.1136/annrheumdis-2012-201505

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

1.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

2.  Contribution of inherited factors to rheumatoid arthritis.

Authors:  C M Deighton; J Wentzel; G Cavanagh; D F Roberts; D J Walker
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

3.  Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion.

Authors:  K Aho; T Palosuo; M Heliövaara; P Knekt; P Alha; R von Essen
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

4.  The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study.

Authors:  A del Puente; W C Knowler; D J Pettitt; P H Bennett
Journal:  Arthritis Rheum       Date:  1988-10

5.  Rheumatoid factors antedating clinical rheumatoid arthritis.

Authors:  K Aho; M Heliövaara; J Maatela; T Tuomi; T Palosuo
Journal:  J Rheumatol       Date:  1991-09       Impact factor: 4.666

6.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.

Authors:  Markus M J Nielen; Dirkjan van Schaardenburg; Henk W Reesink; Rob J van de Stadt; Irene E van der Horst-Bruinsma; Margret H M T de Koning; Moud R Habibuw; Jan P Vandenbroucke; Ben A C Dijkmans
Journal:  Arthritis Rheum       Date:  2004-02

7.  Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

Authors:  I Vallbracht; J Rieber; M Oppermann; F Förger; U Siebert; K Helmke
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

8.  Clinical significance of rheumatoid factor isotypes in seropositive arthritis.

Authors:  T Jónsson; H Valdimarsson
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

9.  Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden.

Authors:  Lisbeth Ärlestig; Mohammed Mullazehi; Heidi Kokkonen; Joacim Rocklöv; Johan Rönnelid; Solbritt Rantapää Dahlqvist
Journal:  Ann Rheum Dis       Date:  2011-11-29       Impact factor: 19.103

10.  A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.

Authors:  Ewa Berglin; Leonid Padyukov; Ulf Sundin; Göran Hallmans; Hans Stenlund; Walther J Van Venrooij; Lars Klareskog; Solbritt Rantapää Dahlqvist
Journal:  Arthritis Res Ther       Date:  2004-05-11       Impact factor: 5.156

View more
  48 in total

1.  Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody-Positive Patients Without Rheumatoid Arthritis.

Authors:  Julia A Ford; Xinyi Liu; Allison A Marshall; Alessandra Zaccardelli; Maria G Prado; Charlene Wiyarand; Bing Lu; Elizabeth W Karlson; Peter H Schur; Kevin D Deane; Jeffrey A Sparks
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-12       Impact factor: 4.794

2.  Elevated IgA Plasmablast Levels in Subjects at Risk of Developing Rheumatoid Arthritis.

Authors:  Jennifer D Kinslow; Lisa K Blum; Kevin D Deane; M Kristen Demoruelle; Yuko Okamoto; Mark C Parish; Sarah Kongpachith; Lauren J Lahey; Jill M Norris; William H Robinson; V Michael Holers
Journal:  Arthritis Rheumatol       Date:  2016-10       Impact factor: 10.995

3.  Rheumatoid arthritis in the Women's Health Initiative: methods and baseline evaluation.

Authors:  Lewis H Kuller; Rachel H Mackey; Brian T Walitt; Kevin D Deane; V Michael Holers; William H Robinson; Jeremy Sokolove; Yuefang Chang; Larry W Moreland
Journal:  Am J Epidemiol       Date:  2014-02-24       Impact factor: 4.897

Review 4.  Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.

Authors:  Anca I Catrina; Kevin D Deane; Jose U Scher
Journal:  Rheumatology (Oxford)       Date:  2014-12-23       Impact factor: 7.580

5.  Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.

Authors:  Melissa E Munroe; Rufei Lu; Yan D Zhao; Dustin A Fife; Julie M Robertson; Joel M Guthridge; Timothy B Niewold; George C Tsokos; Michael P Keith; John B Harley; Judith A James
Journal:  Ann Rheum Dis       Date:  2016-01-25       Impact factor: 19.103

Review 6.  T cell subsets: an integral component in pathogenesis of rheumatic heart disease.

Authors:  Devinder Toor; Neha Sharma
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 7.  Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis.

Authors:  V Michael Holers
Journal:  Curr Opin Immunol       Date:  2013-11-08       Impact factor: 7.486

Review 8.  Strategies to predict rheumatoid arthritis development in at-risk populations.

Authors:  Elizabeth W Karlson; Dirkjan van Schaardenburg; Annette H van der Helm-van Mil
Journal:  Rheumatology (Oxford)       Date:  2014-08-04       Impact factor: 7.580

9.  Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.

Authors:  Melissa E Munroe; Evan S Vista; Joel M Guthridge; Linda F Thompson; Joan T Merrill; Judith A James
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

10.  Monocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women.

Authors:  Elizabeth V Arkema; Bing Lu; Susan Malspeis; Elizabeth W Karlson; Karen H Costenbader
Journal:  Biomark Med       Date:  2015-07-30       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.